Spectrum of cognitive impairment in neurocysticercosis Differences according to disease phase

Neurology

Volumn 78, Issue 12, 2012, Pages 861-866

  Rodrigues, C L ^a   De Andrade, D C ^a,b   Livramento, J A ^a   Machado, L R ^a   Abraham, R ^a   Massaroppe, L ^c   Lucato, L T ^b   Caramelli, P ^d  

^a Faculdade de Medicina   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Departamento de Engenharia   (Brazil)

^d Universidade Federal   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; FATALITY; HUMAN; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ADOLESCENT; AGE; CALCINOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGICAL ASPECT; SEIZURE; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGE FACTORS; CALCINOSIS; COGNITION DISORDERS; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PROGRESSION; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; SEIZURES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84860328933     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824c46d1     Document Type: Article

References (30)

1. Garcia HH, Gonzalez AE, Evans CA, Gilman RH, Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003;362:547-556.
2. Carpio A. Neurocysticercosis: An update. Lancet Infect Dis 2002;2:751-762. (Pubitemid 35434561)
3. Sorvillo F, Wilkins P, Shafir S, Eberhard M. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis 2011;17:1-6.
4. Canelas HM. Neurocysticercosis: Incidence, diagnosis and clinical forms. Arq Neuropsiquiatr 1962;20:1-16.
5. Agapejev S. Aspectos clínico-epidemiológicos da neurocisticercose no Brasil. Arq Neuropsiquiatr 2003;61:822-828.
6. Ciampi de Andrade D, Rodrigues CL, Abraham R, et al. Cognitive impairment and dementia in neurocysticercosis: A cross-sectional controlled study. Neurology 2010;74: 1288-1295.
7. Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62: 1934-1938. (Pubitemid 38738199)
8. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA 1984;252:1905-1907.
9. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption, II. Addiction 1993;88:791-804. (Pubitemid 23194530)
10. Nitrini R, Caramelli P, Bottino CM, et al, Academia Brasileira de Neurologia. Diagnosis of Alzheimer's disease in Brazil: Cognitive and functional evaluation-recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Arq Neuropsiquiatr 2005;63:720-727. (Pubitemid 41232702)
11. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183. (Pubitemid 32667348)
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed. Washington, DC: American Psychiatric Association; 1994.
13. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1988;23:89-97. (Pubitemid 18038426)
14. Forlenza OV, Vieira AHG, Nobrega JPS, et al. Psychiatric manifestations in neurocysticercosis: A study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 1997;62:612-616. (Pubitemid 27281265)
15. Ramirez-Bermudez J, Higuera J, Sosa AL, Lopez-Meza E, Lopez-Gomez M, Corona T. Is dementia reversible in patients with neurocysticercosis? J Neurol Neurosurg Psychiatry 2005;76:1164-1166. (Pubitemid 41081296)
16. Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado L dos R, Leite CC. The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: Impact on characterization of the scolex and lesion burden. Am J Neuroradiol 2007;28:1501-1504. (Pubitemid 47462936)
17. Folstein MF. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arq Neuropsiquiatr 2003;61: 777-781. (Pubitemid 37236632)
19. Wechsler D. Wechsler Memory Scale-Revised. San Antonio: Psychological Corporation; 1997.
20. Morris JC. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) part 1: Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165. (Pubitemid 19239715)
21. Bertolucci PH, Okamoto IH, Brucki SM, Siviero MO, Toniolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to Brazilian elderly. Arq Neuropsiquiatr 2001;59:532-536. (Pubitemid 33607047)
22. Nitrini R, Caramelli P, Herrera E Jr, et al. Performance of illiterate and literate nondemented elderly subjects in two tests of longterm memory. J Int Neuropsychol Soc 2004; 10:634-638. (Pubitemid 39077203)
23. Stroop R. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
24. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community J Gerontol 1982;37:323-329. (Pubitemid 12117513)
25. Sotelo J, Diaz-Olavarrieta C. Neurocysticercosis: Changes after 25 years of medical therapy. Arch Med Res 2010;41: 62-63.
26. Tavares AR Jr. Psychiatric disorders in neurocysticercosis. Br J Psychiatry 1993;163:839.
27. Ramírez-Bermudez J, Corona T. Manifestaciones neuropsiquiatricas de la cisticercosis cerebral. Arch Neurocien 2005;10:92-94.
28. Hewagama SS, Darby JD, Sheorey H, Daffy JR. Seizures related to praziquantel therapy in neurocysticercosis. Med J Aust 2010;193:246-247.
29. Garcia HH, Gonzalez AE, Gilman RH. Cysticercosis of the central nervous system: How should it be managed? Curr Opin Infect Dis 2011;24:423-427.
30. Góngora-Rivera F, Soto-Hernández JL, Guevara P, Sotelo-Morales J. In neurocysticercosis, CSF cytokines correlate with cerebral blood flow velocities. Neurology 2008;71: 1119-1922.